17-76391001-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_022066.4(UBE2O):c.3821C>T(p.Thr1274Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,613,650 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022066.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UBE2O | NM_022066.4 | c.3821C>T | p.Thr1274Met | missense_variant | 18/18 | ENST00000319380.12 | NP_071349.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UBE2O | ENST00000319380.12 | c.3821C>T | p.Thr1274Met | missense_variant | 18/18 | 1 | NM_022066.4 | ENSP00000323687.6 | ||
UBE2O | ENST00000587127.1 | c.2363C>T | p.Thr788Met | missense_variant | 10/10 | 1 | ENSP00000468498.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152254Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000478 AC: 12AN: 251004Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135700
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461396Hom.: 0 Cov.: 30 AF XY: 0.00000825 AC XY: 6AN XY: 726996
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152254Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74390
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 10, 2022 | The c.3821C>T (p.T1274M) alteration is located in exon 18 (coding exon 18) of the UBE2O gene. This alteration results from a C to T substitution at nucleotide position 3821, causing the threonine (T) at amino acid position 1274 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at